Cardioxyl Pharmaceuticals Inc., a small privately held biotechnology company in Chapel Hill that’s developing drugs for cardiovascular disease, will be … Continue reading Chapel Hill’s Cardioxyl gets potential $2 billion buyout deal from Bristol-Myers Squibb